The weight of obesity in breast cancer progression and metastasis: clinical and molecular perspectives.

[1]  L. Del Valle,et al.  Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models , 2019, Breast Cancer Research.

[2]  J. Schneider,et al.  Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities , 2019, Cancers.

[3]  S. Volinia,et al.  Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset , 2019, Cancers.

[4]  C. Giordano,et al.  Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth. , 2019, The American journal of pathology.

[5]  L. Gu,et al.  Association of serum leptin with breast cancer , 2019, Medicine.

[6]  J. Morales-Romero,et al.  Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico , 2019, Clinical breast cancer.

[7]  N. Beerenwinkel,et al.  Neutrophils escort circulating tumour cells to enable cell cycle progression , 2019, Nature.

[8]  C. Giordano,et al.  Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms , 2019, Cancers.

[9]  Xin Shi,et al.  Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression , 2018, Cell Communication and Signaling.

[10]  Le-hua Shi,et al.  Survival Mechanisms and Influence Factors of Circulating Tumor Cells , 2018, BioMed research international.

[11]  Haiyan Lu,et al.  Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence , 2018, Cell Communication and Signaling.

[12]  H. Pan,et al.  An updated systematic review and meta-analysis , 2018 .

[13]  K. Hunter,et al.  Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence , 2018, Nature Communications.

[14]  Xiaohu Tang,et al.  Leptin Signaling Mediates Obesity-Associated CSC Enrichment and EMT in Preclinical TNBC Models , 2018, Molecular Cancer Research.

[15]  S. Rabbani,et al.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications , 2018, Front. Oncol..

[16]  A. Ridley,et al.  Rho GTPase signaling complexes in cell migration and invasion , 2018, The Journal of cell biology.

[17]  S. Kambhampati,et al.  Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway , 2018, BMC Cancer.

[18]  Kshitij Srivastava,et al.  Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence. , 2017, Cell metabolism.

[19]  Fei-hu Ji,et al.  Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2 , 2017, Cellular Oncology.

[20]  M. Myers,et al.  STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. , 2017, Endocrine-related cancer.

[21]  A. Aboussekhra,et al.  Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity , 2017, Molecular and Cellular Biology.

[22]  M. Wong,et al.  Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer , 2017, PloS one.

[23]  Li Chen,et al.  The association between obesity related adipokines and risk of breast cancer: a meta-analysis , 2017, Oncotarget.

[24]  M. Krampera,et al.  Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog , 2017, Cancer biology & medicine.

[25]  M. El-Shinawi,et al.  Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer , 2017, Experimental and therapeutic medicine.

[26]  E. Giannoni,et al.  Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors , 2017, Front. Oncol..

[27]  J. Chang,et al.  Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial , 2017, PloS one.

[28]  Cyrus M. Ghajar,et al.  Circulating and disseminated tumor cells: harbingers or initiators of metastasis? , 2017, Molecular oncology.

[29]  G. Hunter,et al.  Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy. , 2016, Journal of the Academy of Nutrition and Dietetics.

[30]  V. Weaver,et al.  From transformation to metastasis: deconstructing the extracellular matrix in breast cancer , 2016, Cancer and Metastasis Reviews.

[31]  C. Giordano,et al.  Leptin, obesity and breast cancer: progress to understanding the molecular connections. , 2016, Current opinion in pharmacology.

[32]  Changhua Wang,et al.  APPL1-Mediating Leptin Signaling Contributes to Proliferation and Migration of Cancer Cells , 2016, PloS one.

[33]  Fei-hu Ji,et al.  Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2 , 2016, Journal of Experimental & Clinical Cancer Research.

[34]  W. Demark-Wahnefried,et al.  Exploring effects of presurgical weight loss among women with stage 0–II breast cancer: protocol for a randomised controlled feasibility trial , 2016, BMJ Open.

[35]  Hong Wang,et al.  Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages , 2016, Oncotarget.

[36]  M. Altbach,et al.  Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol , 2016, BMC Cancer.

[37]  A. McTiernan,et al.  Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial. , 2016, Cancer research.

[38]  Andrew R. Chin,et al.  Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications , 2016, Clinical Cancer Research.

[39]  Fei-hu Ji,et al.  Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion. , 2016, International journal of oncology.

[40]  Elisa de Stanchina,et al.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT , 2016, Cell.

[41]  Mengjie Yan,et al.  The role of platelets in the tumor microenvironment: From solid tumors to leukemia. , 2016, Biochimica et biophysica acta.

[42]  C. Giordano,et al.  Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy , 2016, Scientific Reports.

[43]  W. Petri,et al.  Leptin Regulation of Immune Responses. , 2016, Trends in molecular medicine.

[44]  Yupei Zhao,et al.  Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance. , 2016, Medical hypotheses.

[45]  J. Gimble,et al.  Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers , 2015, Breast Cancer Research.

[46]  J. Manson,et al.  Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. , 2015, JAMA oncology.

[47]  V. Sheppard,et al.  An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods. , 2015, Contemporary clinical trials.

[48]  H. Cao,et al.  Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells , 2015, Cancer biology & therapy.

[49]  N. Habermann,et al.  No effect of caloric restriction or exercise on radiation repair capacity. , 2015, Medicine and science in sports and exercise.

[50]  J. Gu,et al.  Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production , 2015, Oncotarget.

[51]  Jer-Yen Yang,et al.  Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression. , 2015, Cancer research.

[52]  B. Győrffy,et al.  Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity , 2015, Oncotarget.

[53]  S. C. Chafe,et al.  Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. , 2015, Cancer research.

[54]  A. Assiri,et al.  Resistin, Visfatin, Adiponectin, and Leptin: Risk of Breast Cancer in Pre- and Postmenopausal Saudi Females and Their Possible Diagnostic and Predictive Implications as Novel Biomarkers , 2015, Disease markers.

[55]  C. Giordano,et al.  A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo , 2015, Journal of cellular and molecular medicine.

[56]  R. Carrio,et al.  Paracrine Interactions between Adipocytes and Tumor Cells Recruit and Modify Macrophages to the Mammary Tumor Microenvironment: The Role of Obesity and Inflammation in Breast Adipose Tissue , 2015, Cancers.

[57]  B. Hennessy,et al.  Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer , 2015, Clinical Medicine Insights. Oncology.

[58]  D. Altman,et al.  Obesity and the outcome of young breast cancer patients in the UK: the POSH study. , 2015 .

[59]  E. Yagüe,et al.  Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway , 2014, Breast Cancer Research.

[60]  C. Madeddu,et al.  Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer , 2014, Journal of Cellular and Molecular Medicine.

[61]  N. Gebruers,et al.  Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review , 2014, Breast Cancer Research and Treatment.

[62]  Jian Jian Li,et al.  Breast cancer stem cells: Multiple capacities in tumor metastasis. , 2014, Cancer letters.

[63]  Y. Qi,et al.  Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer , 2014, Journal of the National Cancer Institute.

[64]  A. McTiernan,et al.  Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[65]  Alexander Quarshie,et al.  Obesity induced a leptin‐Notch signaling axis in breast cancer , 2014, International journal of cancer.

[66]  J. Rich,et al.  Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. , 2013, Endocrine-related cancer.

[67]  Yihai Cao,et al.  Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity. , 2013, Cell metabolism.

[68]  R. Gonzalez-Perez,et al.  Leptin’s Pro-Angiogenic Signature in Breast Cancer , 2013, Cancers.

[69]  Liqin Wang,et al.  The Association between Leptin Level and Breast Cancer: A Meta-Analysis , 2013, PloS one.

[70]  Xiaofei Xu,et al.  Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion. , 2013, Carcinogenesis.

[71]  L. Gómez-Oliván,et al.  The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA 15‐3 are Reliable Biomarkers of Breast Cancer , 2013, Journal of clinical laboratory analysis.

[72]  J. Forbes,et al.  Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  C. Hennequin,et al.  Séquelles esthétiques de la radiothérapie adjuvante dans le traitement conservateur du cancer du sein localisé , 2012 .

[74]  C. Hennequin,et al.  [Late sequelae and cosmetic outcome after radiotherapy in breast conserving therapy]. , 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[75]  L. Zelek,et al.  Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies , 2012, Breast Cancer Research and Treatment.

[76]  Shanchun Guo,et al.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. , 2012, Biochimica et biophysica acta.

[77]  C. Giordano,et al.  Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells. , 2012, Cancer research.

[78]  D. Sharma,et al.  Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires β-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways* , 2012, The Journal of Biological Chemistry.

[79]  J. L. Ding,et al.  ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. , 2011, Blood.

[80]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[81]  Jeffrey E. Green,et al.  An in vitro system to study tumor dormancy and the switch to metastatic growth. , 2011, Journal of visualized experiments : JoVE.

[82]  Lily Yang,et al.  Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. , 2011, Endocrine-related cancer.

[83]  J. Yarnold,et al.  Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[84]  J. Rich,et al.  Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. , 2011, Endocrine-related cancer.

[85]  L. Otvos,et al.  Glioblastoma-derived Leptin Induces Tube Formation and Growth of Endothelial Cells: Comparison with VEGF Effects , 2011, BMC Cancer.

[86]  R. Greil,et al.  Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  Edi Brogi,et al.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.

[88]  Shanchun Guo,et al.  Notch, IL-1 and Leptin Crosstalk Outcome (NILCO) Is Critical for Leptin-Induced Proliferation, Migration and VEGF/VEGFR-2 Expression in Breast Cancer , 2011, PloS one.

[89]  R. Gonzalez-Perez,et al.  Vascular Endothelial Growth Factor Receptor-2 Couples Cyclo-Oxygenase-2 with Pro-Angiogenic Actions of Leptin on Human Endothelial Cells , 2011, PloS one.

[90]  Yibin Kang,et al.  Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.

[91]  S. Chua,et al.  Tumorigenesis and Neoplastic Progression Leptin Receptor Signaling Supports Cancer Cell Metabolism through Suppression of Mitochondrial Respiration in Vivo , 2010 .

[92]  Shanchun Guo,et al.  Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation. , 2010, Cellular signalling.

[93]  F. Thong,et al.  Leptin regulates MMP-2, TIMP-1 and collagen synthesis via p38 MAPK in HL-1 murine cardiomyocytes , 2010, Cellular & Molecular Biology Letters.

[94]  J. Cuzick,et al.  Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[95]  R. M. Simpson,et al.  Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. , 2010, Cancer research.

[96]  G. Mantovani,et al.  Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications , 2010, Journal of Molecular Medicine.

[97]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[98]  B. Asselain,et al.  Shortened Survival and More Metastasis Recurrences among Overweight Breast Cancer Patients , 2009, The breast journal.

[99]  R. Weinberg,et al.  Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.

[100]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[101]  K. Czene,et al.  Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? , 2009, British Journal of Cancer.

[102]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[103]  G. Hobbs,et al.  Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population , 2008, Cancer Epidemiology Biomarkers & Prevention.

[104]  F. Anania,et al.  Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. , 2008, Cancer research.

[105]  Candida N. Perera,et al.  Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. , 2008, The Journal of endocrinology.

[106]  B. Sternfeld,et al.  Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer , 2008, Cancer Causes & Control.

[107]  Roger R. Gomis,et al.  TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 , 2008, Cell.

[108]  Marnie L. Gruen,et al.  Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. , 2007, American journal of physiology. Cell physiology.

[109]  Li Zhang,et al.  Adipocytokines and breast cancer risk. , 2007, Chinese medical journal.

[110]  Paula D. Bos,et al.  Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.

[111]  Yarong Wang,et al.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.

[112]  Xuetao Cao,et al.  Involvement of leptin signaling in the survival and maturation of bone marrow‐derived dendritic cells , 2006, European journal of immunology.

[113]  C. Mantzoros,et al.  Leptin Receptor Expression and Signaling in Lymphocytes: Kinetics During Lymphocyte Activation, Role in Lymphocyte Survival, and Response to High Fat Diet in Mice1 , 2006, The Journal of Immunology.

[114]  M. Hou,et al.  Serum adiponectin and leptin levels in Taiwanese breast cancer patients. , 2006, Cancer letters.

[115]  F. Révillion,et al.  Messenger RNA Expression of Leptin and Leptin Receptors and their Prognostic Value in 322 Human Primary Breast Cancers , 2006, Clinical Cancer Research.

[116]  T. Funahashi,et al.  High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels , 2006, International journal of cancer.

[117]  A. Russo,et al.  Increased Expression of Leptin and the Leptin Receptor as a Marker of Breast Cancer Progression: Possible Role of Obesity-Related Stimuli , 2006, Clinical Cancer Research.

[118]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[119]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[120]  S. Loi,et al.  Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[121]  E. Straface,et al.  Leptin Promotes Differentiation and Survival of Human Dendritic Cells and Licenses Them for Th1 Priming 1 , 2005, The Journal of Immunology.

[122]  H. Nagawa,et al.  Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer , 2004, Clinical Cancer Research.

[123]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[124]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[125]  C. Myers,et al.  Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment , 2003, Breast Cancer Research.

[126]  R. Sun,et al.  Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. , 2003, Biochemical and biophysical research communications.

[127]  M. Vasson,et al.  Leptin Regulates Functional Capacities of Polymorphonuclear Neutrophils , 2003, Free radical research.

[128]  V. Sánchez-Margalet,et al.  Leptin receptor (Ob‐R) expression is induced in peripheral blood mononuclear cells by in vitro activation and in vivo in HIV‐infected patients , 2002, Clinical and experimental immunology.

[129]  Ju Yong Lee,et al.  Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro , 2001, Experimental & Molecular Medicine.

[130]  C. Wahlestedt,et al.  Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[131]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[132]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[133]  P. Bischof,et al.  Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. , 2000, Molecular human reproduction.

[134]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[135]  W Vach,et al.  Vascular grading of angiogenesis: prognostic significance in breast cancer , 2000, British Journal of Cancer.

[136]  S. Andò,et al.  SHC–α5β1 Integrin Interactions Regulate Breast Cancer Cell Adhesion and Motility , 1999 .

[137]  G. Garcı́a-Cardeña,et al.  Biological action of leptin as an angiogenic factor. , 1998, Science.

[138]  M. Lane,et al.  Leptin regulates proinflammatory immune responses , 1998 .

[139]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[140]  A. Tutt,et al.  3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). , 2017, Breast.

[141]  Katarzyna A Rejniak,et al.  Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. , 2016, Advances in experimental medicine and biology.

[142]  Kun Yu,et al.  Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway. , 2014, Molecular medicine reports.

[143]  D. Sharma,et al.  Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. , 2013, Neoplasia.

[144]  L. Norton,et al.  International consensus guidelines for advanced breast cancer ( ABC 1 ) , 2012 .

[145]  M. Watson,et al.  Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease , 2012, Breast Cancer Research and Treatment.

[146]  D. Cutter,et al.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials , 2012, The Lancet.

[147]  M. Ewertz,et al.  Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[148]  R. Nieves-Alicea,et al.  Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells , 2008, Clinical & Experimental Metastasis.

[149]  T. Giordano,et al.  NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF , 2007, Nature Medicine.

[150]  G. Frühbeck,et al.  Intracellular signalling pathways activated by leptin. , 2006, The Biochemical journal.